En Es
Categories

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests
Products Covid-19NewsSummary
Close

Covid-19 Roche Diagnostics

Clinical Laboratory

SARS-CoV-2 Test
cobas SARS-CoV-2 Test

The cobas SARS-CoV-2 Test is a qualitative assay that allows the detection of nucleic acids in samples from patients who meet COVID-19 (coronavirus) clinical and/or epidemiological criteria and is intended for use on the automated, high throughput cobas 6800/8800 Systems. The single-well dual target assay includes both specific detection of SARS-CoV-2 (COVID-19 Coronavirus) and pan-sarbecovirus detection for the sarbecovirus subgenus family that includes SARS-CoV-2.
More details

Anti-SARS-CoV-2 Test
Elecsys Anti-SARS-CoV-2

The Elecsys Anti-SARS-CoV-2 is an immunoassay intended for qualitative detection of antibodies to SARS‑CoV‑2 in human serum and plasma (K2‑EDTA, K3‑EDTA, Li‑heparin) to be used as an aid in identifying individuals with an adaptive immune response to SARS‑CoV‑2, indicating recent or prior infection. The electrochemiluminescence immunoassay (ECLIA) uses a recombinant protein representing the nucleocapsid (N) antigen for the determination of antibodies against SARS-CoV-2 and is intended for use on cobas e immunoassay analyzers.
More details

IL-6 Immunoassay
Elecsys IL-6 immunoassay

The Elecsys IL-6 immunoassay is an in vitro diagnostic test for the quantitative determination of IL 6 (interleukin 6) in human serum or plasma and is used to help clinicians quickly identify COVID-19 patients with severe inflammatory response who need mechanical ventilation. The Elecsys IL-6 immunoassay is an electrochemiluminescence immunoassay (ECLIA) and is intended for use on cobas e immunoassay analyzers.
More details
Close

News of Roche Diagnostics

Roche lanza Roche Healthcare Consulting

24 Oct 2018
Roche lanza Roche Healthcare Consulting
Roche (Basilea, Suiza) ha lanzado Roche Healthcare Consulting, un servicio de consultoría especializado que tiene como objetivo ayudar a los líderes en los laboratorios, hospitales y otros grupos de atención médica a optimizar su desempeño operativo, clínico y financiero.

 
Read More

Roche Launches Roche Healthcare Consulting

18 Oct 2018
Roche Launches Roche Healthcare Consulting
Roche (Basel, Switzerland) has launched Roche Healthcare Consulting, a specialized consulting service that aims to help leaders in laboratories, hospitals and other healthcare groups optimize their operational, clinical and financial performance.
Read More
Close

About Roche Diagnostics

Number of Employees: 1000+
Year of Establishment: 1896
Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests
FaceBook Twitter Google+ Linked in
Anti-SARS-CoV-2 Test

Anti-SARS-CoV-2 Test

Model: Elecsys Anti-SARS-CoV-2
Request Information

Description:

The Elecsys Anti-SARS-CoV-2 is an immunoassay intended for qualitative detection of antibodies to SARS‑CoV‑2 in human serum and plasma (K2‑EDTA, K3‑EDTA, Li‑heparin) to be used as an aid in identifying individuals with an adaptive immune response to SARS‑CoV‑2, indicating recent or prior infection.
Read More

Full Description

Description

The Elecsys Anti-SARS-CoV-2 is an immunoassay intended for qualitative detection of antibodies to SARS‑CoV‑2 in human serum and plasma (K2‑EDTA, K3‑EDTA, Li‑heparin) to be used as an aid in identifying individuals with an adaptive immune response to SARS‑CoV‑2, indicating recent or prior infection. The electrochemiluminescence immunoassay (ECLIA) uses a recombinant protein representing the nucleocapsid (N) antigen for the determination of antibodies against SARS-CoV-2 and is intended for use on cobas e immunoassay analyzers. Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Roche Diagnostics (Anti-SARS-CoV-2 Test)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions